Growdea Technologies is an in-silico drug discovery company committed to providing high-quality and scientifically acceptable outcomes to the client of drug design covering small molecules and biologics. We developed an in-house “Therapeutic Platform” called Analogue. This platform has all modules that are required in the initial stage of drug design and development. The platform is based on machine learning algorithms and physics-based principles to screen and validate drug-like molecules.
CITATION OF ANALOGUE BY USERS
- Alkhatabi, H. A., & Alatyb, H. N. (2024). In Silico Design of Peptide Inhibitors Targeting HER2 for Lung Cancer Therapy. Cancers, 16(23), 3979. (IF=4.5)
- Suyash, S., Mishra, A., & Tembhre, M. K. (2024). Mechanistic Explanation of Activation and Inhibition of Crucial Enzymes Involved in Melanin Production. Journal of Computational Biophysics and Chemistry, 1-20. (IF=2.4)
- Sarin, D., Chakraborty, D., Sreenivasan, S., Mishra, A., & Rathore, A. S. (2025). Higher concentration of trehalose dihydrate stabilizes recombinant IgG1 under forced stress conditions. Journal of Pharmaceutical Sciences. (IF=3.7)
- Suyash, S., Khan, W. H., Maitra, P., Jangid, V., Punia, P., & Mishra, A. (2024). Machine Learning Optimization Approach to Design Multi-Epitope Marburg Vaccine Construct. Biosciences Biotechnology Research Asia, 21(4), 1463-1484. (IF=1)
- Varude, P., & Satish, D. (2024). Integrative Computational Design of PD-L1 Inhibitors, Utilizing MD Simulations and DFT Studies to Guide Cancer Treatment through Atomic and Electronic Properties. Journal of Computational Biophysics and Chemistry. (IF=2.4)
- Kizhakethil, R. V., Varma, A. K., Barage, S., Rameshkumar, N., Nagarajan, K., Kumar, A. W. S., & Kamble, S. S. (2025). Repercussions of the calpain cleavage-related missense mutations in the cytosolic domains of human integrin-β subunits on the progression of uterine corpus endometrial carcinoma. International Journal of Molecular Sciences. (IF=4.9)
- Khan, W. H., Khan, N., Tembhre, M. K., Malik, Z., Ansari, M. A., & Mishra, A. (2025). Integrated virtual screening and compound generation targeting H275Y mutation in the neuraminidase gene of oseltamivir-resistant influenza strains. Molecular Diversity. (IF=3.8)